Dong-A Pharmaceutical Co, the largest drug maker here, is likely to reach 1 trillion won in sales this year due to robust sales of its flagship product at home and abroad, Shinhan Investment and Securities said last Friday.
According to the report, the company’s third-quarter sales are forecast to post 248.9 billion won this year, up 2.9 percent from the previous year.
Next year, the comp...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.